Impact of the COVID-19 Pandemic on Breast Cancer Stage at Diagnosis in a Regional Cancer Center in Poland between 2019 and 2021

The COVID-19 pandemic had a negative effect on oncology healthcare services in Poland, with a reduction in the national breast cancer (BC) screening program coverage rates. This article analyzes the impact of the pandemic on BC stage at diagnosis in a regional cancer center in Poland. Records from B...

Descripción completa

Detalles Bibliográficos
Autores principales: Trojanowski, Maciej, Radomyski, Piotr, Matuszewski, Krzysztof, Litwiniuk, Maria, Wierzchosławska, Ewa, Kycler, Witold
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503146/
https://www.ncbi.nlm.nih.gov/pubmed/36143271
http://dx.doi.org/10.3390/jpm12091486
_version_ 1784795890434703360
author Trojanowski, Maciej
Radomyski, Piotr
Matuszewski, Krzysztof
Litwiniuk, Maria
Wierzchosławska, Ewa
Kycler, Witold
author_facet Trojanowski, Maciej
Radomyski, Piotr
Matuszewski, Krzysztof
Litwiniuk, Maria
Wierzchosławska, Ewa
Kycler, Witold
author_sort Trojanowski, Maciej
collection PubMed
description The COVID-19 pandemic had a negative effect on oncology healthcare services in Poland, with a reduction in the national breast cancer (BC) screening program coverage rates. This article analyzes the impact of the pandemic on BC stage at diagnosis in a regional cancer center in Poland. Records from BC multidisciplinary team (MDT) meetings that took place in the years 2019–2021 were gathered. BC clinical staging was compared. Age-related subgroups were additionally analyzed to reflect possible screening program disruptions. The total number of BC cases fell by 8% in 2020 compared with 2019, with a 14% fall in the screening age group. In 2021, a stage shift was observed, with stage II BC becoming most frequently diagnosed (as opposed to stage I BC in 2019 and 2020). A statistically significant increase in the number of stage III BC cases was observed in 2021.
format Online
Article
Text
id pubmed-9503146
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-95031462022-09-24 Impact of the COVID-19 Pandemic on Breast Cancer Stage at Diagnosis in a Regional Cancer Center in Poland between 2019 and 2021 Trojanowski, Maciej Radomyski, Piotr Matuszewski, Krzysztof Litwiniuk, Maria Wierzchosławska, Ewa Kycler, Witold J Pers Med Article The COVID-19 pandemic had a negative effect on oncology healthcare services in Poland, with a reduction in the national breast cancer (BC) screening program coverage rates. This article analyzes the impact of the pandemic on BC stage at diagnosis in a regional cancer center in Poland. Records from BC multidisciplinary team (MDT) meetings that took place in the years 2019–2021 were gathered. BC clinical staging was compared. Age-related subgroups were additionally analyzed to reflect possible screening program disruptions. The total number of BC cases fell by 8% in 2020 compared with 2019, with a 14% fall in the screening age group. In 2021, a stage shift was observed, with stage II BC becoming most frequently diagnosed (as opposed to stage I BC in 2019 and 2020). A statistically significant increase in the number of stage III BC cases was observed in 2021. MDPI 2022-09-11 /pmc/articles/PMC9503146/ /pubmed/36143271 http://dx.doi.org/10.3390/jpm12091486 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Trojanowski, Maciej
Radomyski, Piotr
Matuszewski, Krzysztof
Litwiniuk, Maria
Wierzchosławska, Ewa
Kycler, Witold
Impact of the COVID-19 Pandemic on Breast Cancer Stage at Diagnosis in a Regional Cancer Center in Poland between 2019 and 2021
title Impact of the COVID-19 Pandemic on Breast Cancer Stage at Diagnosis in a Regional Cancer Center in Poland between 2019 and 2021
title_full Impact of the COVID-19 Pandemic on Breast Cancer Stage at Diagnosis in a Regional Cancer Center in Poland between 2019 and 2021
title_fullStr Impact of the COVID-19 Pandemic on Breast Cancer Stage at Diagnosis in a Regional Cancer Center in Poland between 2019 and 2021
title_full_unstemmed Impact of the COVID-19 Pandemic on Breast Cancer Stage at Diagnosis in a Regional Cancer Center in Poland between 2019 and 2021
title_short Impact of the COVID-19 Pandemic on Breast Cancer Stage at Diagnosis in a Regional Cancer Center in Poland between 2019 and 2021
title_sort impact of the covid-19 pandemic on breast cancer stage at diagnosis in a regional cancer center in poland between 2019 and 2021
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503146/
https://www.ncbi.nlm.nih.gov/pubmed/36143271
http://dx.doi.org/10.3390/jpm12091486
work_keys_str_mv AT trojanowskimaciej impactofthecovid19pandemiconbreastcancerstageatdiagnosisinaregionalcancercenterinpolandbetween2019and2021
AT radomyskipiotr impactofthecovid19pandemiconbreastcancerstageatdiagnosisinaregionalcancercenterinpolandbetween2019and2021
AT matuszewskikrzysztof impactofthecovid19pandemiconbreastcancerstageatdiagnosisinaregionalcancercenterinpolandbetween2019and2021
AT litwiniukmaria impactofthecovid19pandemiconbreastcancerstageatdiagnosisinaregionalcancercenterinpolandbetween2019and2021
AT wierzchosławskaewa impactofthecovid19pandemiconbreastcancerstageatdiagnosisinaregionalcancercenterinpolandbetween2019and2021
AT kyclerwitold impactofthecovid19pandemiconbreastcancerstageatdiagnosisinaregionalcancercenterinpolandbetween2019and2021

Ejemplares similares